Arkolith/Insider Trading/XERS/Form 4

Hecht Beth

See RemarksXeris Biopharma Holdings, Inc. (XERS) · full profile →Form 4 · filed Mar 4, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$104K
Net Open-Market Flow
-$104K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 2, 2026Sell(S)17K$6.24$103K1.2M
Mar 2, 2026Sell(S)100$7.06$7061.2M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001652410-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML